NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
41 hedge funds and large institutions have $158M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 7 closing their positions.
450% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 2
364% more capital invested
Capital invested by funds: $34.1M → $158M (+$124M)
286% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 7
129% more call options, than puts
Call options by funds: $2.03M | Put options by funds: $888K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
95% more funds holding
Funds holding: 21 → 41 (+20)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$30M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$27.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$15M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$11.6M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.5M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$1.01M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$399K |
| 4 |
OC
Oppenheimer & Co
New York
|
-$287K |
| 5 |
Goldman Sachs
New York
|
-$277K |
NDRM Hedge Fund Activity: Q3 2015 in Review
41 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2015, worth a combined $158M — up 364% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new NDRM positions and 7 closed out — a net gain of 20 holders — while 11 added to existing stakes and 2 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $30M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $11.5M sold.
- 41 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2015, up from 21 in Q2 2015.
- Funds reported $158M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2015, up 364% quarter-over-quarter.
- 27 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2015 and 7 closed out, a net change of +20 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2015 was Redmile Group, an estimated $30M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2015 was Adage Capital Partners, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2015.